Literature DB >> 9632617

Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells.

A Joe1, R Verdon, S Tzipori, G T Keusch, H D Ward.   

Abstract

An enzyme-linked immunosorbent assay-based attachment model using the human intestinal cell line Caco-2A was developed to study attachment of Cryptosporidium parvum sporozoites in vitro and to assess potential inhibitors of sporozoite binding. In this system, attachment was related to sporozoite dose, incubation time, and host cell differentiation status. Polyclonal antibodies to C. parvum as well as glycoprotein inhibitors of a sporozoite lectin reduced attachment. This model will be a valuable tool in elucidating specific molecules and mechanisms involved in sporozoite-host cell attachment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632617      PMCID: PMC108364     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  A novel T. cruzi heparin-binding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells.

Authors:  E Ortega-Barria; M E Pereira
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

2.  Sexual stage development of cryptosporidia in the Caco-2 cell line.

Authors:  M Buraud; E Forget; L Favennec; J Bizet; J G Gobert; A M Deluol
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 3.  Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around.

Authors:  J J McCoy; B J Mann; W A Petri
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines.

Authors:  S J Upton; M Tilley; D B Brillhart
Journal:  FEMS Microbiol Lett       Date:  1994-05-15       Impact factor: 2.742

5.  Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro.

Authors:  D H Hamer; H Ward; S Tzipori; M E Pereira; J P Alroy; G T Keusch
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Human secretory immunoglobulin A anti-Entamoeba histolytica antibodies inhibit adherence of amebae to MDCK cells.

Authors:  J C Carrero; M Y Díaz; M Viveros; B Espinoza; E Acosta; L Ortiz-Ortiz
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.

Authors:  P S Doyle; J Crabb; C Petersen
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Identification and partial purification of a lectin on the surface of the sporozoite of Cryptosporidium parvum.

Authors:  D M Thea; M E Pereira; D Kotler; C R Sterling; G T Keusch
Journal:  J Parasitol       Date:  1992-10       Impact factor: 1.276

9.  Complete development of Cryptosporidium parvum in a human endometrial carcinoma cell line.

Authors:  K R Rasmussen; N C Larsen; M C Healey
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

10.  Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death.

Authors:  J K Griffiths; R Moore; S Dooley; G T Keusch; S Tzipori
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

View more
  18 in total

1.  Human intestinal and biliary cryptosporidiosis.

Authors:  Xian-Ming Chen; Nicholas F LaRusso
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  Quantification of in vitro and in vivo Cryptosporidium parvum infection by using real-time PCR.

Authors:  Nihal T Godiwala; Alain Vandewalle; Honorine D Ward; Brett A Leav
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

3.  Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells.

Authors:  Amna Hashim; Grace Mulcahy; Billy Bourke; Marguerite Clyne
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15.

Authors:  A M Cevallos; X Zhang; M K Waldor; S Jaison; X Zhou; S Tzipori; M R Neutra; H D Ward
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells.

Authors:  R C Langer; M W Riggs
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.

Authors:  Michael W Riggs; Deborah A Schaefer; Sushila J Kapil; Lise Barley-Maloney; Lance E Perryman
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 7.  The cell biology of cryptosporidium infection.

Authors:  Steven P O'Hara; Xian-Ming Chen
Journal:  Microbes Infect       Date:  2011-03-31       Impact factor: 2.700

8.  Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection.

Authors:  D F McCole; L Eckmann; F Laurent; M F Kagnoff
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  The Cryptosporidium parvum C-Type Lectin CpClec Mediates Infection of Intestinal Epithelial Cells via Interactions with Sulfated Proteoglycans.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

10.  The role of Cryptosporidium parvum-derived phospholipase in intestinal epithelial cell invasion.

Authors:  R C G Pollok; V McDonald; P Kelly; M J G Farthing
Journal:  Parasitol Res       Date:  2003-02-26       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.